The goal of the IPBS is to validate tissue and serum biomarkers prospectively for clinical use. Although there is general agreement that molecular markers have the potential to improve the ability to diagnose and treat men with prostate cancer, to date none have achieved clinical utility. The SPORE solicited applications for candidate biomarkers. UCLA submitted applications on p27, PSCA, PTEN and other markers based on its track record of discovery and publication on these genes. The SPORE commissioned a meta-analysis of published work to prioritize biomarkers for both prospective and retrospective study. P27 was one of a small number of biomarkers chosen for prospective evaluation, with both UCLA and Dana Farber selected as sites for performing the assay. UCLA's Pathology and Biostatistics Core have been integrally involved in the IPBS. The Pathology Core participated in a prospective study to evaluate the effect of tissue fixation on biomarkers, submitting a series of cases to a central facility for processing. UCLA's Pathology Core has also agreed to participate fully in the study, including collection and processing of specimens according to the protocol. Slides for p27 will be sent to UCLA for staining and scoring. The IPBS was targeted as the first inter-SPORE study that would utilize the tools and infrastructure selected and developed for the NBN. The Cancer Biolnformatics Grid (caBIG) tool set referred to as the caTissue Suite was identified early on (in 2004) by an informatics team from several of the SPORE sites as an ideal software solution that would meet the needs of the NBN. However, the delivery of the caTissue suite was delayed to the point that the IPBS informatics working group elected to move forward with a short-term solution while each of the 11 sites works out details of implementation of caTissue at their respective institutions. UCLA has participated in this entire process, including the NBN informatics meetings, the IPBS informatics working group, and efforts to clarify adoption issues related to relevant caBIG tools. In addition, the IPBS informatics working group selected the open source protocol tracker software suite called pTracker developed at UCLA by the Computing Technologies Research Lab to support the IPBS needs until caTissue mature to the point that it and related tools can used.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA092131-10
Application #
8291332
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2011
Total Cost
$10
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Miller, Eric T; Salmasi, Amirali; Reiter, Robert E (2018) Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med 8:
Navarro, Héctor I; Goldstein, Andrew S (2018) HoxB13 mediates AR-V7 activity in prostate cancer. Proc Natl Acad Sci U S A 115:6528-6529
Mitra, Mithun; Ho, Linda D; Coller, Hilary A (2018) An In Vitro Model of Cellular Quiescence in Primary Human Dermal Fibroblasts. Methods Mol Biol 1686:27-47
Li, Jiayun; Speier, William; Ho, King Chung et al. (2018) An EM-based semi-supervised deep learning approach for semantic segmentation of histopathological images from radical prostatectomies. Comput Med Imaging Graph 69:125-133
Kang, Jung J; Reiter, Robert E; Kummer, Nicolas et al. (2018) Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy. Am J Clin Oncol 41:1-5
Lee, Ha Neul; Mitra, Mithun; Bosompra, Oye et al. (2018) RECK isoforms have opposing effects on cell migration. Mol Biol Cell 29:1825-1838
Aggarwal, Rahul; Huang, Jiaoti; Alumkal, Joshi J et al. (2018) Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol 36:2492-2503
Cheng, Larry C; Li, Zhen; Graeber, Thomas G et al. (2018) Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer. J Vis Exp :
Park, Jung Wook; Lee, John K; Sheu, Katherine M et al. (2018) Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science 362:91-95
Tan, Nelly; Shen, Luyao; Khoshnoodi, Pooria et al. (2018) Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. J Urol 199:1218-1223

Showing the most recent 10 out of 339 publications